Great Expectations: Induced Pluripotent Stem Cell Technologies in Neurodevelopmental Impairments
December 2020
in “
International Journal of Medical Sciences
”
Studysummary This article reviews the development and use of induced pluripotent stem cell models and artificial organoids for studying neurodevelopmental disorders, but it reports no new clinical findings.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
The document discussed the transformation of somatic cells into induced pluripotent stem cells (iPSCs) as a significant advancement in stem-cell research, particularly for neurodevelopmental disorders like GDD/ID, epilepsy, ASD, and ADHD. iPSCs, which are similar to embryonic stem cells but without the ethical and immune rejection issues, were used to model these disorders by reprogramming cells with disease-causing mutations. This approach provided valuable samples for studying the mechanisms and pathogenesis of these conditions, aiding in drug development and treatment planning. The article highlighted the development of iPSCs, disease models, and artificial organoids, emphasizing their potential to enhance understanding and treatment of neurodevelopmental impairments.
